BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, June 22, 2026
Home » Topics » Briefs » Other news to note

Other news to note
Other news to note RSS Feed RSS

Other news to note for Oct. 7, 2021

Oct. 7, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspira Women’s Health, Capnostics, Dariohealth, Genoox, Healthverity, Mynd Life Sciences, Neurometrix, Ondine Biomedical, Pavmed.
Read More

Other news to note for Oct. 7, 2021

Oct. 7, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aicuris, Alx, Blade, Calliditas, Curative, Cytodyn, Debiopharm, Dexa, Evox, Flightpath, Genkyotex, Immunoprecise, Janssen, Johnson & Johnson, KGK, Mid-Atlantic, Moderna, Neurorx, Northwestern, Pierre Fabre, Psyched, Relief, Talem, Tryp.
Read More

Other news to note for Oct. 6, 2021

Oct. 6, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aetion, Arterys, Bone Health Technologies, Cognetivity Neurosciences, Cue Health, Google, Lighthouse Imaging, Nanodx, Onemednet, Precision Optics, Sectra, Sengine Precision Medicine, Skywater Technology, Sword Health, Unilabs, Vigilant Technologies.
Read More

Other news to note for Oct. 6, 2021

Oct. 6, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abbvie, Astrazeneca, Eurobio, Fortress, Gemini, Landos, Lumen, Mosaic, Q-State, Strongbridge, Surrozen, Xeris.
Read More

Other news to note for Oct. 5, 2021

Oct. 5, 2021
Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Aipharma Global Holdings, Anpac Bio-Medical Science, Appili, Atara, Beximco, Biocytogen, Biovaxys Technology, Cynata, Diaprost, Envigo RMS, Eyegene, Fujifilm, Genelux, GL Capital, GL Mountrose Investment Two, Hutchison Whampoa Guangzhou Baiyunshan Chinese Medicine, Hutchmed, Immutep, JCR, Jiangsu Recbio Technology, Moderna, Newsoara, Otsuka, Pierre Fabre, Race Oncology, Radiopharm Theranostics, Sanofi, Sanofi Bangladesh, Shenzhen Rhegen, Shionogi, Signalchem Lifesciences, Sihuan, Soligenix, Sumitomo Dainippon, Sunovion, Takeda, Therapeutic Solutions International, Tonix, Trilink, VBI Vaccines, Viiv Healthcare, Wuhan Rhecogen, Xuanzhu.
Read More

Other news to note for Oct. 5, 2021

Oct. 5, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aidoc, Allscripts, Caremetx, Esight, Fluidfile, Merlin Entertainments, Riverain Technologies, Samsung Electronics, Sonendo, Veradigm, Vuno.
Read More

Other news to note for Oct. 5, 2021

Oct. 5, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aditxt, Aipharma, Alloy, Alzecure, April19, Dr. Falk, Enveric, Evenus, Lanier, Mindmed, Mydecine, Nabriva, Pacira, Regenerx, Renexxion, Secarna, Taysha, Vedanta, Vistagen.
Read More

Other news to note for Oct. 4, 2021

Oct. 4, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Accuray, Annoviant, Archangel of Mercy, Bico Group, Brain Scientific, Cepheid, C-Rad AB, Hemovent, Iwound, Mercy Supply Collaborative, Microport, Mig Capital, Mig Verwaltungs, Mirion Technologies, Piezo Motion, Novocure, Orasure, Qinstruments, Tgen Tech.
Read More

Other news to note for Oct. 4, 2021

Oct. 4, 2021
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Anpac, Astrazeneca, Atara, Autotelic, Beximco, Casma, Cassiopea, Clearside, Compugen, Cosmo, Dynavax, Dyne, Eyegene, Forge, Inhibikase, Inozyme, Keros, LB Pharmaceuticals, Minovia, Oncotelic, Oragenics, Pierre Fabre, Sandoz, Solid, Stridebio, Therapeutic Solutions, Tonix, Trilink.
Read More

Other news to note for Oct. 1, 2021

Oct. 1, 2021
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aethlon Medical, Caredx, Daxor, Envveno Medical, Eurofins Viracor, Hancock Jaffe Laboratories, PPD, Qiagen, Siemens, Treace Medical Concepts.
Read More
Previous 1 2 … 278 279 280 281 282 283 284 285 286 … 1400 1401 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 22, 2026.
  • Alicorn synthesizes new AAK1 inhibitors

    BioWorld Science
    Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
  • Illustration of glucose in the blood stream

    CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research

    BioWorld Science
    Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
  • Illustration of a child's brain

    Saniona reports preclinical data for SAN-2668

    BioWorld Science
    Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
  • CC-3 antibody shows antitumoral activity in penile cancer

    BioWorld Science
    Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing